(Q54393433)

English

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Victoria E Shaw

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

Lucinda J. Billingham

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

David Cunningham

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

John P Neoptolemos

12

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

1

object named as

Nicola E Annels

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

11

object named as

Hardev Pandha

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

author name string

Rachel F Gabitass

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

Pippa Corrie

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

Martin Eatock

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

David Smith

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

Jonathan Wadsley

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

Gary Middleton

13

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

publication date

29 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

63

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

175-183

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

https://scigraph.springernature.com/pub.10.1007/s00262-013-1502-y

0 references

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1502-Y

21 January 2018

Identifiers

10.1007/S00262-013-1502-Y

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24292263

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54393433&oldid=1771288361"